Skip to main content
. 2016 Feb 8;11(3):2255–2260. doi: 10.3892/ol.2016.4204

Table I.

Characteristics of 16 MM patients with bortezomib-induced severe pulmonary complications.

First author, year Age, years Gender MM type Previous history of lung injury Status of MM prior to bortezomib therapy Prior transplantation Ref.
Miyakoshi et al, 2006 47 F IgG Invasive pulmonary aspergillosis Relapse Auto-PBSCT (6)
59 F IgA Pulmonary embolism Relapse Auto-PBSCT
48 F IgD No Relapse Unrelated bone marrow transplantation
53 F Unknown No Relapse Auto-PBSCT
Boyer et al, 2006 66 M Unknown No Relapse No (8)
Zappasodi et al, 2007 66 M Unknown COPD Refractory Unknown (9)
Dun et al, 2010 72 M IgG No Relapse Unknown (10)
51 M IgD No Refractory Unknown
72 F IgG No New No
68 F IgG No Relapse Unknown
72 M IgG No Relapse Unknown
Kang et al, 2010 67 M IgG Unknown New No (11)
Yamaguchi et al, 2012 64 M IgG No Relapse Auto-PBSCT (12)
Vandeix et al, 2012 74 M IgC No New No (13)
Chew et al, 2007 66 M IgG Unknown New Auto-PBSCT (14)
Pitini et al, 2007 51 M IgG No Relapse Auto-PBSCT (15)

Ig, immunoglobulin; COPD, chronic obstructive pulmonary disease; auto-PBSCT, autologous peripheral blood stem cell transplantation; M, male; F, female; MM, multiple myeloma.